Protocols in Revision

Testicular Tumor

• TI-CE - Carboplatin 7 / Etoposide 400, Testicular Carcinoma, part B PID 781 V1.1

Hodgkin Lymphoma

• TEAM - Thiotepa 5 / Etoposide 100 / Cytarabine 200 / Melphalan 200, before autologous Stem Cell Transplantation PID 406 V1.1

Breast Cancer

• Eribulin 1.23 / Margetuximab 15, Breast Cancer PID 1872 V1.1

Mantle Cell Lymphoma

• TEAM - Thiotepa 5 / Etoposide 100 / Cytarabine 200 / Melphalan 200, before autologous Stem Cell Transplantation PID 406 V1.1

Multiple Myeloma

• Bortezomib 1.3 / Cyclophosphamide 900 / Dexamethasone 40, Multiple Myeloma PID 532 V1.2
• Bortezomib 1.3 / Doxorubicin 9 / Dexamethasone 40, Multiple Myeloma PID 529 V1.2
• Bortezomib 1.3 / Lenalidomide 25 / Dexamethasone 20 / Isatuximab 10, multiple myeloma, induction, IB, cycle 1 PID 41 V1.2
• Bortezomib 1.3 / Lenalidomide 25 / Dexamethasone 20 / Isatuximab 10, multiple myeloma, induction, IB, cycle 2-3 PID 42 V1.2
• Bortezomib 1.5 / Cyclophosphamide 300 / Dexamethasone 40, Multiple Myeloma, cycle 1-2 PID 1852 V1.1
• High-dose Melphalan 200 before Autologous Stem Cell Transplantation, Multiple Myeloma PID 528 V2.2

NHL, B-Cell Type, Diffuse Large Cell

• TEAM - Thiotepa 5 / Etoposide 100 / Cytarabine 200 / Melphalan 200, before autologous Stem Cell Transplantation PID 406 V1.1

NHL, B-Cell Type, Follicular grade IIIb

• TEAM - Thiotepa 5 / Etoposide 100 / Cytarabine 200 / Melphalan 200, before autologous Stem Cell Transplantation PID 406 V1.1

Stem Cell Transplantation, Autologous

• High-dose Melphalan 200 before Autologous Stem Cell Transplantation, Multiple Myeloma PID 528 V2.2
• TEAM - Thiotepa 5 / Etoposide 100 / Cytarabine 200 / Melphalan 200, before autologous Stem Cell Transplantation PID 406 V1.1

Soft Tissue Sarcoma

• Dacarbazine 300, Soft Tissue Sarcoma PID 1212 V1.1
• Doxorubicin 15 / Dacarbazine 250, Soft Tissue Sarcoma PID 1214 V1.1
• Doxorubicin 75 / Dacarbazine 400, Soft Tissue Sarcoma PID 1213 V1.1